Rapport Therapeutics
RAPP
#5519
Rank
NZ$2.50 B
Marketcap
NZ$42.34
Share price
-1.82%
Change (1 day)
-12.76%
Change (1 year)

P/S ratio for Rapport Therapeutics (RAPP)

P/S ratio as of November 2026 (TTM): 69.4

According to Rapport Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.28. At the end of 2026 the company had a P/S ratio of 77.2.

P/S ratio history for Rapport Therapeutics from 2024 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202677.2
2025N/A
2024N/A